Partner With Us NRI

Abbott India Ltd share Price

Company details

6M Return 16.90%
1Y Return 22.76%
Mkt Cap.(Cr) 44,999.01
Volume 403
Div Yield 1.29%
OI Chg %
Volume 403

Open Free Trading Account Online with ICICIDIRECT

Power brands continue to drive growth…

About The Stock

    Abbott India is one of the fastest growing listed MNC pharma companies. It has outperformed the industry on a consistent basis in women’s health, GI, metabolic, pain, CNS among others.

    • The company’s top five brands - (Mixtard, Thyronorm, Novomix, Udiliv and Duphaston) together posted revenue CAGR of ~6.6% MAT, March 2019-22
    • Abbott has 140+ brands in segments of women’s health, gastroenterology, metabolics, CNS, multi-specialty, vaccines & consumer health


    Abbott India’s numbers were strong on the back of 14.2% YoY growth in top five therapies (anti-diabetic, GI, VMN, anti-infective, CNS) according to MAT March 2022, IQVIA.

    • Sales were up 15% YoY to ₹ 1255 crore
    • EBITDA was at ₹ 294 crore, up 43% YoY with margins at 23.4%
    • Consequent PAT was at ₹ 211 crore (up 39% YoY)

Click here for full recommendation

Research view on more stocks


Investment recommendation

Power brands continue to drive growth…

Call Date

13 Feb 2023

Entry Price


Target Price



12-18 Month



Operating Profit

Profit after Tax


Reserves and Surplus



Operating Profit

Profit after Tax




Abbott India Ltd Stocks COMPARISION


Equity Capital: 2,819.79 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 9,527.59 7,252.76
LAST 3M 42,415.10 -9,114.21
LAST 6M 72,085.06 4,510.60
LAST 12M 156,258.18 -37,934.40

Abbott India Ltd Information

Stock PE (TTM)


Promoter Holding


Book Value







  • Abbott India Limited is a pharmaceutical company and has a market capitalization of Rs. 40,158.27 crores as of 25th August 2021. The company has reported its revenue income from operations of Rs. 4,310 crores at the end of March 2021. The Bombay Stock Exchange (BSE) and National Stock Exchange have assigned the number 500488 and scrip code ABBOTINDIA. As of 25th August 2021, Abbott India Limited was trading at Rs. 18,898.90.

    Abbott India Limited was a subsidiary of Abbott Laboratories, USA. Since 1944 they are working for the advancement of healthcare in India. It was incorporated on 22nd August '1944 as Boots Pure Drug Company (India) Ltd. In July '2002, they have changed their name to Abbott India Ltd. The company features a headquarters in north suburban Chicago; they serve in additional than 160 countries with leading medical devices, diagnostics, nutrition products, and branded generic medicines. The company has 3,585 permanent employees on the roll. The Promoter & Promoter group holding in the company has remained constant since the last year, i.e., 74.99%. The Balance of 25.01% is by others which involve Mutual Funds (3.42%), Venture Capital Funds (0.13%), foreign portfolio investors (0.25%), Financial Institutions/Banks (0.42%), Insurance Companies (1.96%), and non-Institutions (18.03%).

    In June 2021, the company has a profit of Rs. 195.76 crores, which had increased by 7.87% from Rs. 180.35 crores in the quarter ending June’20. From Rs. 279.04 crores in March 2020, Abbott India Limited EPS has risen to Rs. 325.04 crores in March 2021. EBIDTA margin has also increased by 23.3% in 2021 (Rs. 1,002 crores) compared to 2020 (Rs. 871 crores). Abbott India Limited stock closed at Rs. 18,806.75 on 23rd August '2021 (NSE) and has a return of 25.77% in the last six months (On 23rd March 2021 stock market price Rs. 13,959.80) and 35.36% in the previous year. Book value per share has increased to 1,225 in FY 2020-21 from 1,144 in FY 2019-20. The interest coverage ratio has been decreased to 51.7 times in FY 2020-21 from 95.1 times in FY 2019-20 due to the accounting impact of IND AS 116 –Lease.

Registered Address

Unit No 3 Corporate Park, Sion Trombay Road Chembur, Mumbai, Maharashtra, 400071

Tel : 91-22-67978888/50461000/2000/1119
Email : investorrelations.india:abbott.com
Website : http://www.abbott.co.in


Sharepro Services India P Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 500488
Book Closure Date (Month) : Jul
BSE Group : A
ISIN : INE358A01014

FAQ’s on Abbott India Ltd Shares

You can buy Abbott India Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Abbott India Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Mar 21, 2023 04:01 PM the closing price of Abbott India Ltd was ₹ 21,177.00.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Mar 21, 2023 04:01 PM, the market cap of Abbott India Ltd stood at ₹ 44,999.01.

The latest PE ratio of Abbott India Ltd as of Mar 21, 2023 04:01 PM is 48.71

The latest PB ratio of Abbott India Ltd as of Mar 21, 2023 04:01 PM is 0.06

The 52-week high of Abbott India Ltd is ₹ 22,481.80 while the 52-week low is ₹ 15,868.70

According to analyst recommendations, Abbott India Ltd has a “Buy” rating for the long term.

Download Our App

market app
market app